✦ LIBER ✦

Prophylactic Therapy With Valganciclovir in High-Risk (Cytomegalovirus D+/R−) Kidney Transplant Recipients: A Single-Center Experience

✍ Scribed by M. Montejo; M. Porto; O. Carmon; S. Zárraga; J. Gainza; J.J. Amenabar; J. Goikoetxea; E. Bereciartua; I. Lampreabe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylactic Therapy With Valgancyclovir

✍ M. Montejo; E. Montejo; M. Gastaca; A. Valdivieso; J.R. Fernandez; M. Testillano 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 98 KB

The Efficacy and Safety of 200 Days Valg

✍ A. Humar; Y. Lebranchu; F. Vincenti; E. A. Blumberg; J. D. Punch; A. P. Limaye; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

Outcomes of Kidney Transplantation Recip

✍ Lu, K.; Wang, H.-P.; Chen, Y.-S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Effect of Induction Therapy With Thymogl

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 134 KB

PIN56 Cost-Effectiveness Model to Evalua

✍ C. Fernández-Rivera; J. Torre-Cisneros; L. Guirado-Perich; I. Oyagüez; E. Ruiz-b 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

The Effects of Preemptive Therapy Using

✍ Saracino, A.; Colucci, R.; Latorraca, A.; Muscaridola, N.; Procida, C.; Di Noia, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 222 KB